Business Description
Alvotech
NAICS : 325412
SIC : 2834
ISIN : LU2458332611
Description
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | -0.28 | |||||
| Debt-to-Equity | -3.44 | |||||
| Debt-to-EBITDA | -6.25 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -1.25 | |||||
| Beneish M-Score | 0.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | -43.8 | |||||
| 3-Year EPS without NRI Growth Rate | -50.3 | |||||
| 3-Year FCF Growth Rate | -64.6 | |||||
| 3-Year Book Growth Rate | 0.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 103.88 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.64 | |||||
| 9-Day RSI | 67.08 | |||||
| 14-Day RSI | 59.84 | |||||
| 6-1 Month Momentum % | -5.67 | |||||
| 12-1 Month Momentum % | 19.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | |||||
| Quick Ratio | 1.92 | |||||
| Cash Ratio | 0.74 | |||||
| Days Inventory | 212.69 | |||||
| Days Sales Outstanding | 51.31 | |||||
| Days Payable | 135.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -10.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.81 | |||||
| Operating Margin % | -5.35 | |||||
| Net Margin % | -112.65 | |||||
| FCF Margin % | -76.56 | |||||
| ROA % | -41.88 | |||||
| ROIC % | -1.73 | |||||
| ROC (Joel Greenblatt) % | -55.05 | |||||
| ROCE % | -34.06 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 75.16 | |||||
| PS Ratio | 8.46 | |||||
| EV-to-EBIT | -22.12 | |||||
| EV-to-EBITDA | -25.62 | |||||
| EV-to-Revenue | 12.36 | |||||
| EV-to-FCF | -16.08 | |||||
| Earnings Yield (Greenblatt) % | -4.52 | |||||
| FCF Yield % | -7.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alvotech Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 360.192 | ||
| EPS (TTM) (€) | -1.696 | ||
| Beta | 0 | ||
| Volatility % | 55.35 | ||
| 14-Day RSI | 59.84 | ||
| 14-Day ATR (€) | 0.179928 | ||
| 20-Day SMA (€) | 11.0625 | ||
| 12-1 Month Momentum % | 19.36 | ||
| 52-Week Range (€) | 9.56 - 16.75 | ||
| Shares Outstanding (Mil) | 301.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alvotech Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alvotech Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alvotech Frequently Asked Questions
What is Alvotech(STU:Z45)'s stock price today?
The current price of STU:Z45 is €11.50. The 52 week high of STU:Z45 is €16.75 and 52 week low is €9.56.
When is next earnings date of Alvotech(STU:Z45)?
The next earnings date of Alvotech(STU:Z45) is 2025-03-21 Est..
Does Alvotech(STU:Z45) pay dividends? If so, how much?
Alvotech(STU:Z45) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers